Reviewers Commentary: This article adds to the growing body of literature on the role of PARP inhibitors in tumors with DNA repair defects.
Ruta Sahasrabudhe, PhD
Articles by Ruta Sahasrabudhe, PhD
Latest Updated Articles
Olaparib for Patients With DNA Repair Defects and Metastatic Prostate Cancer: Is it Time Yet?Published: April 23rd 2018 | Updated: